AptarGroup, Inc. (ATR)

NYSE: ATR · IEX Real-Time Price · USD
95.03
-3.21 (-3.27%)
Sep 30, 2022 4:00 PM EDT - Market closed
-3.27%
Market Cap 6.21B
Revenue (ttm) 3.33B
Net Income (ttm) 230.92M
Shares Out 65.34M
EPS (ttm) 3.44
PE Ratio 27.63
Forward PE 22.99
Dividend $1.52 (1.60%)
Ex-Dividend Date Jul 26, 2022
Volume 451,396
Open 96.12
Previous Close 98.24
Day's Range 94.87 - 97.76
52-Week Range 94.03 - 135.81
Beta 0.62
Analysts Buy
Price Target 124.29 (+30.8%)
Earnings Date Oct 27, 2022

About ATR

AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable prima... [Read more...]

Industry Containers & Packaging
IPO Date Apr 21, 1993
CEO Stephan Tanda
Employees 13,000
Stock Exchange NYSE
Ticker Symbol ATR
Full Company Profile

Financial Performance

In 2021, AptarGroup's revenue was $3.23 billion, an increase of 10.17% compared to the previous year's $2.93 billion. Earnings were $244.10 million, an increase of 14.04%.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for ATR stock is "Buy." The 12-month stock price forecast is 124.29, which is an increase of 30.79% from the latest price.

Price Target
$124.29
(30.79% upside)
Analyst Consensus: Buy
Stock Forecasts

News

GEF or ATR: Which Is the Better Value Stock Right Now?

GEF vs. ATR: Which Stock Is the Better Value Option?

Other symbols: GEF
1 week ago - Zacks Investment Research

Aptar Expands Pharmaceutical Services; Announces Exclusive Collaboration Between Aptar Pharma and Fluidda

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Expands Pharmaceutical Services and Announces Exclusive Collaboration Between Aptar Pharma and Fluidda.

1 week ago - Business Wire

Aptar Appoints Matthew L. Trerotola to its Board of Directors

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar announced today that Matt Trerotola has joined its Board of Directors.

2 weeks ago - Business Wire

GEF vs. ATR: Which Stock Is the Better Value Option?

GEF vs. ATR: Which Stock Is the Better Value Option?

Other symbols: GEF
1 month ago - Zacks Investment Research

AptarGroup (ATR) Q2 Earnings Match Estimates

AptarGroup (ATR) delivered earnings and revenue surprises of 0% and 0.48%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Aptar Reports Second Quarter 2022 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Second Quarter 2022 Results

2 months ago - Business Wire

9 Cheap Defensive Stocks

#Morningstar #StockMarketToday #stockpicks The earnings of these companies are less sensitive to the economy. Morningstar's chief U.S. market strategist Dave Sekera explains that these stocks are also u...

2 months ago - Morningstar

In the Midwest, there's a 15% loss of workforce in manufacturing, says AptarGroup's Stephan Tanda

Stephan Tanda, AptarGroup CEO, joins 'The Exchange' to discuss the rise in job abandonment and lack of workforce in the manufacturing industry.

2 months ago - CNBC Television

Aptar Declares Quarterly Dividend

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar today declared a quarterly cash dividend of $0.38 per share.

2 months ago - Business Wire

Aptar Releases 2021 Corporate Sustainability / ESG Report

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar released its 2021 Corporate Sustainability / ESG Report entitled Better Takes Shape

3 months ago - Business Wire

GPK vs. ATR: Which Stock Should Value Investors Buy Now?

GPK vs. ATR: Which Stock Is the Better Value Option?

Other symbols: GPK
3 months ago - Zacks Investment Research

SON vs. ATR: Which Stock Is the Better Value Option?

SON vs. ATR: Which Stock Is the Better Value Option?

Other symbols: SON
4 months ago - Zacks Investment Research

Aptar Named Among the 100 Best Corporate Citizens for 2022

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar has been named to 3BL Media's 100 Best Corporate Citizens ranking for the second year in a row.

4 months ago - Business Wire

SON or ATR: Which Is the Better Value Stock Right Now?

SON vs. ATR: Which Stock Is the Better Value Option?

Other symbols: SON
4 months ago - Zacks Investment Research

AptarGroup (ATR) Q1 Earnings Meet Estimates

AptarGroup (ATR) delivered earnings and revenue surprises of 0% and 1.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Aptar Reports First Quarter 2022 Results

CRYSTAL LAKE, Ill--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported first qu...

5 months ago - Business Wire

Analysts Estimate AptarGroup (ATR) to Report a Decline in Earnings: What to Look Out for

AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

GPK or ATR: Which Is the Better Value Stock Right Now?

GPK vs. ATR: Which Stock Is the Better Value Option?

Other symbols: GPK
5 months ago - Zacks Investment Research

Aptar Announces Passing of Director Jesse Wu

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR) today announced with deep sadness that Jesse Wu, a director of the Company, has passed away. Mr. Wu served on the Board of Directors sin...

5 months ago - Business Wire

SON vs. ATR: Which Stock Should Value Investors Buy Now?

SON vs. ATR: Which Stock Is the Better Value Option?

Other symbols: SON
6 months ago - Zacks Investment Research

AptarGroup, Inc. Announces Pricing of $400 Million of 3.600% Senior Notes due 2032

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced the p...

7 months ago - Business Wire

Aptar Named One of Barron's 100 Most Sustainable Companies in the U.S. for the Fourth Consecutive Year

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, has again been named one of Barron...

7 months ago - Business Wire

AptarGroup (ATR) Q4 Earnings and Revenues Beat Estimates

AptarGroup's (ATR) fourth-quarter 2021 top line improves on solid performance across all segments.

7 months ago - Zacks Investment Research

AptarGroup (ATR) Tops Q4 Earnings and Revenue Estimates

AptarGroup (ATR) delivered earnings and revenue surprises of 1.09% and 1.93%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

Aptar Reports Fourth Quarter and Annual 2021 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported fourth ...

7 months ago - Business Wire